Intestinal Behçet and Crohn’s disease: two sides of the same coin
Behçet’s disease (BD) and Crohn’s disease (CD) are chronic immune-mediated, inflammatory disorders affecting many different systems (joints, skin, eyes,…
ped-rheum.biomedcentral.com
Ustekinumab Effective and Safe in Crohn’s Colitis
The New England Journal of Medicine has reported the results of a large clinical trial demonstrating the…
rheumnow.com
Anti-IL-23 Therapy Effective in Crohn’s Disease
Lancet has reported the results of risankizumab, an interleukin-23 (IL-23) inhibitor, in Crohn’s disease.…
rheumnow.com
AbbVie’s JAK-1 inhibitor hits the mark in Crohn’s disease
A Phase 2 study showed upadacitinib significantly reduced patients’ intestinal inflammation, results that should push the drug into late-stage testing.
biopharmadive.com